1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        SAM Branded Generics Market – By Therapeutic Application

1.3.2        SAM Branded Generics Market – By Distribution Channel

1.3.3        SAM Branded Generics Market – By Drug Class

1.3.4        SAM Branded Generics Market – By Formulation Type

1.3.5        SAM Branded Generics Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           SAM Branded Generics Market – Market Landscape

4.1         Overview

4.2         SAM PEST Analysis

4.3         Experts Opinion

5.           SAM Branded Generics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Penetration of Branded Generics

5.2         Market Restraints

5.2.1        Switching Brands, Poorer Clinical Outcomes and Adverse Effects of Generic Medications

5.3         Market Opportunities

5.3.1        Product Differentiation

5.4         Future Trends

5.4.1        Encouraging Utility of Branded Generics by Healthcare Providers and Professionals

5.5         Impact Analysis

6.           Branded Generics Market– SAM Analysis

6.1         SAM Branded Generics Market Revenue Forecast and Analysis

6.2         SAM Branded Generics Market, By Country - Forecast and Analysis

7.           SAM Branded Generics Market Revenue and Forecast To 2028– by Therapeutic Application

7.1         Overview

7.2         SAM Branded Generics Market Revenue Share, By Therapeutic Application: Market Revenue and Forecast Analysis (US$ Billion)

7.3         Oncology

7.3.1        Overview

7.3.2        Oncology Market Revenue and Forecast to 2028 (US$ Billion)

7.4         Cardiovascular Diseases

7.4.1        Overview

7.4.2        Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.5         Diabetes

7.5.1        Overview

7.5.2        Diabetes Market Revenue and Forecast to 2028 (US$ Billion)

7.6         Neurology

7.6.1        Overview

7.6.2        Neurology Market Revenue and Forecast to 2028 (US$ Billion)

7.7         Gastrointestinal Diseases

7.7.1        Overview

7.7.2        Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.8         Dermatology Diseases

7.8.1        Overview

7.8.2        Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.9         Analgesics and Anti-Inflammatory

7.9.1        Overview

7.9.2        Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)

7.10      Others

7.10.1     Overview

7.10.2     Others Market Revenue and Forecast to 2028 (US$ Billion)

8.           SAM Branded Generics Market Analysis and Forecast to 2028 by Distribution Channel

8.1         SAM Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)

8.2         Hospital Pharmacies

8.2.1        Overview

8.2.2        Hospital Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.3         Retail Pharmacies

8.3.1        Overview

8.3.2        Retail Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.4         Online Pharmacies

8.4.1        Overview

8.4.2        Online Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.5         Drug Stores

8.5.1        Overview

8.5.2        Drug Stores: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.           SAM Branded Generics Market Analysis and Forecast to 2028 by Drug Class

9.1         SAM Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)

9.2         Alkylating Agents

9.2.1        Overview

9.2.2        Alkylating Agents: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.3         Antimetabolites

9.3.1        Overview

9.3.2        Antimetabolites: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.4         Hormones

9.4.1        Overview

9.4.2        Hormones: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.5         Anti-hypertensive

9.5.1        Overview

9.5.2        Anti-hypertensive: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.6         Lipid Lowering Drugs

9.6.1        Overview

9.6.2        Lipid Lowering Drugs: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.7         Anti-Depressants

9.7.1        Overview

9.7.2        Anti-Depressants: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.8         Anti-psychotics

9.8.1        Overview

9.8.2        Anti-psychotics: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.9         Anti-epileptic

9.9.1        Overview

9.9.2        Anti-epileptic: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.10      Others

9.10.1     Overview

9.10.2     Others: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

10.        SAM Branded Generics Market Analysis and Forecast to 2028 – by Formulation Type

10.1      Overview

10.2      SAM Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)

10.3      Oral

10.3.1     Overview

10.3.2     Oral Market Revenue and Forecast to 2028 (US$ Billion)

10.4      Parenteral

10.4.1     Overview

10.4.2     Parenteral Market Revenue and Forecast to 2028 (US$ Billion)

10.5      Topical

10.5.1     Overview

10.5.2     Topical Market Revenue and Forecast to 2028 (US$ Billion)

10.6      Others

10.6.1     Overview

10.6.2     Others Market Revenue and Forecast to 2028 (US$ Billion)

11.        SAM Branded Generics Market Revenue and Forecasts to 2028 Country Analysis

11.1      Overview

11.1.1     SAM: Branded Generics Market Revenue and Forecasts to 2028, By Country (%)

11.1.1.1       Argentina Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)

11.1.1.1.1       Overview

11.1.1.1.2       Argentina: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.1.1.1.3       Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.1.1.1.4       Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.1.1.1.5       Argentina: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.1.6       Argentina: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.1.1.2       Brazil: Branded Generics Market Revenue and Forecast to 2028 (US$ Billion)

11.1.1.2.1       Overview

11.1.1.2.2       Brazil: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.1.1.2.3       Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.1.1.2.4       Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.1.1.2.5       Brazil: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.2.6       Brazil: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

11.1.1.3       Rest of South and Central America: Branded Generics Market– Revenue and Forecast to 2028 (USD Billion)

11.1.1.3.1       Overview

11.1.1.3.2       Rest of SAM: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

11.1.1.3.3       Rest of SAM: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

11.1.1.3.4       Rest of SAM: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

11.1.1.3.5       Rest of SAM: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.3.6       Rest of SAM: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

12.        Branded Generics Market–Industry Landscape

12.1      Overview

12.2      Growth Strategies Done by the Companies in the Market (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      MYLAN N.V.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      TEVA PHARMACEUTICAL INDUSTRIES LTD

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      GlaxoSmithKline plc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Bausch Health Companies Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Lupin

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Sanofi

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      ASTRAZENECA PLC.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Dr. Reddy's Laboratories

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Par Pharmaceuticals, INC

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Sandoz International GMBH

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

13.11   Aspen Holdings

13.11.1  Key Facts

13.11.2  Business Description

13.11.3  Products and Services

13.11.4  Financial Overview

13.11.5  SWOT Analysis

13.11.6  Key Developments

13.12   Hetero

13.12.1  Key Facts

13.12.2  Business Description

13.12.3  Products and Services

13.12.4  Financial Overview

13.12.5  SWOT Analysis

13.12.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 2.             Argentina: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 3.             Argentina: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 4.             Argentina: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 5.             Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 6.             Brazil: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 7.             Brazil: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 8.             Brazil: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 9.             Rest of SAM: Branded Generics Market Revenue and Forecasts to 2028, By Therapeutic Application (US$ Billion)

Table 10.          Rest of SAM: Branded Generics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Billion)

Table 11.          Rest of SAM: Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 12.          Rest of SAM: Branded Generics Market, by Formulation Type– Revenue and Forecast to 2028 (US$ Billion)

Table 13.          Organic Developments Done By Companies

Table 14.          Inorganic Developments Done By Companies

Table 15.          Glossary of Terms

LIST OF FIGURES

Figure 1.           SAM Branded Generics Market Segmentation

Figure 2.           SAM Branded Generics Market, By Country

Figure 3.           SAM Branded Generics Market Overview

Figure 4.           Others Segment Held Largest Share of Drug Class Segment in SAM Branded Generics Market

Figure 5.           Brazil is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           SAM: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Impact Analysis of Drivers and Restraints on SAM Branded Generics Market

Figure 9.           SAM Branded Generics Market – By Country Forecast and Analysis – 2019 - 2028

Figure 10.        SAM Branded Generics Market Revenue Share, By Therapeutic Application: Market Analysis and Forecast 2022 and 2028 (%)

Figure 11.        SAM Oncology Market Revenue and Forecast to 2028 (US$ Billion)

Figure 12.        SAM Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)

Figure 13.        SAM Diabetes Market Revenue and Forecast to 2028 (US$ Billion)

Figure 14.        SAM Neurology Market Revenue and Forecast to 2028 (US$ Billion)

Figure 15.        SAM Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)

Figure 16.        SAM Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)

Figure 17.        SAM Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)

Figure 18.        SAM Others Market Revenue and Forecast to 2028 (US$ Billion)

Figure 19.        SAM Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)

Figure 20.        SAM Hospital Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 21.        SAM Retail Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 22.        SAM Online Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 23.        SAM Drug Stores: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 24.        SAM Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)

Figure 25.        SAM Alkylating Agents: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 26.        SAM Antimetabolites: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 27.        SAM Hormones: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 28.        SAM Anti-hypertensive: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 29.        SAM Lipid Lowering Drugs: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 30.        SAM Anti-Depressants: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 31.        SAM Anti-psychotics: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 32.        SAM Anti-epileptic: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 33.        SAM Others: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 34.        SAM Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)

Figure 35.        SAM Oral Market Revenue and Forecast to 2028 (US$ Billion)

Figure 36.        SAM Parenteral Market Revenue and Forecast to 2028 (US$ Billion)

Figure 37.        SAM Topical Market Revenue and Forecast to 2028 (US$ Billion)

Figure 38.        SAM Others Market Revenue and Forecast to 2028 (US$ Billion)

Figure 39.        SAM Branded Generics Market Overview, by Country (2022)

Figure 40.        SAM: Branded Generics Market Revenue and Forecasts to 2028, By Country (%)

Figure 41.        Argentina: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

Figure 42.        Brazil: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

Figure 43.        Rest of SAM: Branded Generics Market Revenue and Forecasts to 2028 (US$ Billion)

Figure 44.        Growth Strategies Done by the Companies in the Market (%)